ONCY - Oncolytics Biotech GAAP EPS of -C$0.08 in-line
- Oncolytics Biotech press release ( NASDAQ: ONCY ): Q3 GAAP EPS of -C$0.08 in-line.
- As of September 30, 2022, the company reported $32.4M in cash and cash equivalents, provides projected runway through key milestones to the end of 2023.
For further details see:
Oncolytics Biotech GAAP EPS of -C$0.08 in-line